Chr. Hansen and Glycom settle HMO patent disputes inherited from Jennewein acquisition

Related Articles

FormattedPicture

BUSINESS NEWS

This week in nutrition news, Chr. Hansen met its expectations of delivering 7% organic growth for the 2020/21 period. The growth is reflected by the company’s... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

H-Proof has landed a patent for its nutraceutical, The Anytime You Drink Vitamin. The black cherry chewable tablets support alcohol metabolism, promote liver health and... Read More

FormattedPicture

FOOD RESEARCH

AB-Biotics’ AB-Kolicare probiotic blend helps reduce the crying or fussing time and episodes of babies with colic. This is according to a new study, which the... Read More

FormattedPicture

BUSINESS NEWS

This week in nutrition news, Norwegian vitamin K2 expert Kappa Bioscience launched a program to lower greenhouse emissions. Sabinsa increased its presence in the UK and... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

A new study has found a mix of the five most abundant Human Milk Oligosaccharides (HMOs) in natural concentrations is safe and tolerable in infant formula. The study... Read More

trans